Drug:
Reaction: WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138958 |
US |
78 | 2 |
Injection site pain, Injection site nodule, Device difficult to use, Drug dose omission by device, Incorrect disposal of product, Accidental exposure to product, Wrong technique in product usage process, |
||||
EVOLOCUMAB, |
||||
| 2 | 25139151 |
US |
1 | |
Joint stiffness, Wrong technique in product usage process, Arthralgia, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 3 | 25139175 |
US |
2 | |
Wrong technique in product usage process, Product administered at inappropriate site, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 4 | 25139268 |
US |
78 | 2 |
Device difficult to use, Drug dose omission by device, Wrong technique in product usage process, Injection site indentation, Accidental exposure to product, Discomfort, |
||||
EVOLOCUMAB, |
||||
| 5 | 25139274 |
US |
61 | 2 |
Eye disorder, Accidental exposure to product, Exposure via skin contact, Liquid product physical issue, Wrong technique in product usage process, Product knowledge deficit, Poor quality product administered, Product complaint, |
||||
PERFLUOROHEXYLOCTANE, |
||||
| 6 | 25139351 |
US |
44 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 7 | 25139382 |
US |
85 | 2 |
Surgery, Wrong technique in product usage process, Device difficult to use, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 8 | 25139471 |
US |
74 | 2 |
Device difficult to use, Drug dose omission by device, Back pain, Musculoskeletal stiffness, Wrong technique in product usage process, |
||||
EVOLOCUMAB, EVOLOCUMAB, ICOSAPENT ETHYL, ALPRAZOLAM, BISOPROLOL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 9 | 25139673 |
US |
63 | |
Drug dose omission by device, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 10 | 25139681 |
US |
||
Dyspnoea, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 11 | 25139709 |
US |
16 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 12 | 25139720 |
US |
1 | |
Wrong technique in product usage process, Incorrect dose administered by device, |
||||
ALBUTEROL SULFATE, |
||||
| 13 | 25139799 |
US |
74 | |
Vocal cord disorder, Dysphonia, Nasal dryness, Liquid product physical issue, Incorrect dose administered by device, Product prescribing issue, Product storage error, Incorrect dosage administered, Wrong technique in product usage process, |
||||
BUDESONIDE, |
||||
| 14 | 25139905 |
US |
65 | |
Wrong technique in product usage process, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, LISINOPRIL, |
||||
| 15 | 25140003 |
US |
75 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 16 | 25140014 |
US |
75 | 1 |
Wrong technique in product usage process, Product delivery mechanism issue, |
||||
VARENICLINE, VARENICLINE, VARENICLINE, VARENICLINE, |
||||
| 17 | 25140017 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 18 | 25140331 |
US |
35 | 1 |
Chest pain, Panic reaction, Anxiety, Asthenia, Dizziness, Tremor, Wrong technique in product usage process, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 19 | 25140623 |
US |
53 | 2 |
Device difficult to use, Drug dose omission by device, Wrong technique in product usage process, Injection site pain, Migraine, |
||||
ERENUMAB-AOOE, UBROGEPANT, |
||||
| 20 | 25140657 |
US |
1 | |
Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 21 | 25140728 |
US |
73 | 2 |
Wrong technique in product usage process, |
||||
APIXABAN, |
||||
| 22 | 25140748 |
CA |
32 | 2 |
COVID-19, Drug ineffective, Influenza like illness, Small intestine ulcer, Therapy interrupted, Intentional dose omission, Incorrect dose administered, Product dose omission issue, Wrong technique in product usage process, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ESZOPICLONE, LEVOTHYROXINE SODIUM, |
||||
| 23 | 25141070 |
US |
70 | 2 |
Arthritis, Accidental exposure to product, Wrong technique in product usage process, Drug dose omission by device, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 24 | 25141119 |
PH |
||
Pulmonary congestion, Cardiac failure congestive, Pneumonia, Dialysis, Cough, Asthenia, Wrong technique in product usage process, Inappropriate schedule of product administration, Underdose, |
||||
TOLVAPTAN, |
||||
| 25 | 25141511 |
US |
40 | 1 |
Dyspepsia, Injection site rash, Injection site erythema, Injection site pain, Wrong technique in product usage process, |
||||
DUPILUMAB, |
||||
| 26 | 25141771 |
US |
39 | 1 |
Needle issue, Wrong technique in product usage process, |
||||
NALTREXONE, FLUOXETINE HYDROCHLORIDE, |
||||
| 27 | 25141939 |
FR |
1 | |
Urinary retention, Urine flow decreased, Wrong technique in product usage process, Intentional product misuse, |
||||
| 28 | 25142041 |
US |
88 | |
Dyspnoea, Drug dose omission by device, Product use in unapproved indication, Wrong technique in product usage process, Device malfunction, |
||||
ALBUTEROL SULFATE, |
||||
| 29 | 25142532 |
US |
||
Wrong technique in product usage process, Product packaging quantity issue, Product dose omission issue, |
||||
RUXOLITINIB, |
||||
| 30 | 25142840 |
DE |
94 | 1 |
Renal impairment, Gastrooesophageal reflux disease, Visual acuity reduced, Speech disorder, Wrong technique in product usage process, |
||||
RIVAROXABAN, |
||||
| 31 | 25146383 |
62 | 1 | |
Wrong technique in product usage process, Syringe issue, Incorrect dose administered by device, |
||||
BIMEKIZUMAB, MELOXICAM, GABAPENTIN, |
||||
| 32 | 25138205 |
US |
53 | 2 |
Wrong technique in product usage process, Feeding disorder, Gastroenteritis viral, Flatulence, Eructation, Gastrooesophageal reflux disease, Diarrhoea, Vomiting, Abdominal pain upper, |
||||
TIRZEPATIDE, |
||||
| 33 | 25138245 |
US |
16 | |
Dyspnoea, Wrong technique in product usage process, Drug dose omission by device, |
||||
ALBUTEROL SULFATE, |
||||
| 34 | 25138250 |
US |
65 | |
Wrong technique in product usage process, Drug dose omission by device, Wrong technique in device usage process, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 35 | 25138251 |
US |
68 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 36 | 25138278 |
US |
64 | |
Incorrect dose administered, Incorrect dose administered, Visual impairment, Wrong technique in product usage process, Device leakage, Wrong technique in device usage process, Product quality issue, |
||||
EXENATIDE, |
||||
| 37 | 25138285 |
US |
2 | |
Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 38 | 25138393 |
US |
2 | |
Wrong technique in device usage process, Wrong technique in product usage process, Product complaint, |
||||
ALBUTEROL SULFATE, |
||||
| 39 | 25138480 |
US |
85 | 1 |
Injury associated with device, Wrong technique in product usage process, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 40 | 25138736 |
US |
66 | 2 |
Injection site indentation, Injection site pruritus, Device difficult to use, Wrong technique in product usage process, Drug dose omission by device, Device use error, |
||||
EVOLOCUMAB, |
||||
| 41 | 25137484 |
US |
||
Wrong technique in product usage process, Injection site pain, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), |
||||
| 42 | 25137793 |
US |
67 | 1 |
Dyspnoea, Wrong technique in device usage process, Wrong technique in product usage process, Product complaint, |
||||
ALBUTEROL SULFATE, |
||||
| 43 | 25137999 |
US |
63 | 2 |
Wrong technique in product usage process, Injection site swelling, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 44 | 25132437 |
US |
59 | 2 |
Bronchitis, Lack of satiety, Weight increased, Influenza, Costochondritis, Parosmia, Nausea, Vomiting, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, PREDNISONE, |
||||
| 45 | 25132542 |
US |
82 | 2 |
Product dose omission issue, Wrong technique in product usage process, Product use issue, |
||||
VELPATASVIR AND SOFOSBUVIR, VELPATASVIR AND SOFOSBUVIR, |
||||
| 46 | 25132706 |
US |
47 | 2 |
Endoscopy, Polyp, Gastroenteritis viral, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 47 | 25132756 |
US |
58 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 48 | 25132764 |
US |
40 | |
Drug dose omission by device, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 49 | 25132773 |
US |
||
Wrong technique in product usage process, Drug dose omission by device, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 50 | 25132804 |
US |
65 | |
Wrong technique in product usage process, Off label use, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 51 | 25133179 |
US |
2 | |
Wrong technique in product usage process, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 52 | 25133319 |
US |
||
Wrong technique in product usage process, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 53 | 25133454 |
US |
2 | |
Pneumonia, Medical procedure, Product communication issue, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, |
||||
| 54 | 25133473 |
US |
||
Device delivery system issue, Wrong technique in product usage process, Product after taste, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 55 | 25133719 |
US |
||
Accidental exposure to product, Wrong technique in product usage process, |
||||
DICLOFENAC, DICLOFENAC SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 56 | 25133906 |
US |
31 | 1 |
Wrong technique in product usage process, Single component of a two-component product administered, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 57 | 25134073 |
US |
||
Wrong technique in product usage process, Eyeglasses therapy, Device delivery system issue, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 58 | 25134389 |
US |
2 | |
Drug ineffective, Wrong technique in product usage process, Abdominal distension, |
||||
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, |
||||
| 59 | 25134501 |
US |
31 | |
Wrong technique in product usage process, Device use error, Product packaging quantity issue, |
||||
VARENICLINE, |
||||
| 60 | 25134554 |
US |
2 | |
Overdose, Wrong technique in product usage process, |
||||
SUMATRIPTAN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 61 | 25134695 |
US |
2 | |
Weight abnormal, Therapeutic product effect variable, Insurance issue, Inability to afford medication, Wrong technique in product usage process, Product availability issue, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 62 | 25134700 |
US |
2 | |
Wrong technique in product usage process, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 63 | 25134742 |
US |
||
Intentional dose omission, Product dose omission issue, Device use issue, Wrong technique in device usage process, Throat irritation, Wrong technique in product usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 64 | 25134755 |
US |
82 | 2 |
Wrong technique in product usage process, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 65 | 25134817 |
US |
||
Oxygen saturation decreased, Device delivery system issue, Wrong technique in product usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 66 | 25134945 |
US |
72 | 1 |
Pruritus, Inappropriate schedule of product administration, Incorrect dose administered, Wrong technique in product usage process, |
||||
DUPILUMAB, |
||||
| 67 | 25135251 |
US |
63 | 1 |
General physical health deterioration, Wrong technique in product usage process, Accidental exposure to product, Device leakage, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 68 | 25135304 |
US |
1 | |
Wrong technique in product usage process, Incorrect dose administered, |
||||
LIOTHYRONINE SODIUM, |
||||
| 69 | 25135352 |
US |
12 | 1 |
Device difficult to use, Accidental exposure to product, Incorrect dose administered by device, Therapeutic product effect incomplete, Off label use, Migraine, Therapeutic response shortened, Wrong technique in product usage process, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, GALCANEZUMAB-GNLM, RIMEGEPANT SULFATE, |
||||
| 70 | 25135591 |
US |
83 | |
Eye disorder, Muscular weakness, Wrong technique in product usage process, Incorrect dose administered, Product dose omission issue, Device issue, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 71 | 25135878 |
PH |
1 | |
Dialysis, Wrong technique in product usage process, Underdose, |
||||
TOLVAPTAN, |
||||
| 72 | 25136169 |
CO |
8 | 1 |
Device issue, Wrong technique in product usage process, |
||||
SOMATROPIN, |
||||
| 73 | 25136630 |
US |
2 | |
Injection site haemorrhage, Arthritis, Wrong technique in product usage process, |
||||
ADALIMUMAB, |
||||
| 74 | 25136775 |
US |
78 | 2 |
Idiopathic pulmonary fibrosis, Nausea, Vomiting, Lipase increased, Cholelithiasis, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, PIRFENIDONE, |
||||
| 75 | 25126292 |
US |
74 | 2 |
Stoma complication, Blister, Hernia, Wrong technique in product usage process, |
||||
ADALIMUMAB, |
||||
| 76 | 25126412 |
US |
||
Sinusitis, Product dose omission issue, Wrong technique in product usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 77 | 25126666 |
US |
||
Dyspnoea, Intentional product use issue, Product dose omission issue, Wrong technique in product usage process, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 78 | 25126906 |
US |
48 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Product lot number issue, |
||||
ALBUTEROL SULFATE, |
||||
| 79 | 25126946 |
US |
53 | 2 |
Psoriasis, Injection site pain, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, |
||||
| 80 | 25126958 |
US |
1 | |
Wrong technique in product usage process, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 81 | 25127123 |
US |
1 | |
Injection site pain, Wrong technique in product usage process, |
||||
BIMEKIZUMAB, |
||||
| 82 | 25127302 |
US |
||
Drug dose omission by device, Wrong technique in device usage process, Device difficult to use, Wrong technique in product usage process, Device mechanical issue, No adverse event, |
||||
TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 83 | 25127343 |
US |
12 | |
Dyspnoea, Discomfort, Drug dose omission by device, Wrong technique in product usage process, Device information output issue, Device deposit issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 84 | 25127392 |
US |
2 | |
Wrong technique in product usage process, Product use complaint, |
||||
AMLODIPINE, |
||||
| 85 | 25127414 |
US |
2 | |
Wrong technique in product usage process, Product use complaint, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 86 | 25127419 |
US |
82 | 2 |
Wrong technique in product usage process, Device difficult to use, Incorrect disposal of product, Product communication issue, Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
| 87 | 25127448 |
US |
54 | 2 |
Injection site haemorrhage, Wrong technique in product usage process, |
||||
ADALIMUMAB, |
||||
| 88 | 25127964 |
BR |
1 | |
Metabolic surgery, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, |
||||
| 89 | 25128019 |
US |
44 | 1 |
Incorrect dose administered, Incorrect dose administered, Wrong technique in product usage process, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 90 | 25128045 |
US |
||
Choking, Foreign body in throat, Wrong technique in product usage process, |
||||
CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, |
||||
| 91 | 25128139 |
US |
66 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 92 | 25128159 |
US |
58 | 2 |
Device adhesion issue, Wrong technique in product usage process, |
||||
PEGFILGRASTIM, |
||||
| 93 | 25128168 |
US |
46 | 2 |
Product dose omission issue, Wrong technique in product usage process, Sinusitis, Pain, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 94 | 25128214 |
US |
57 | |
Wrong technique in product usage process, Off label use, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 95 | 25128483 |
US |
68 | |
Drug dose omission by device, Wrong technique in product usage process, Dyspnoea, Device deposit issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 96 | 25128688 |
US |
||
Wrong technique in product usage process, |
||||
BELUMOSUDIL, |
||||
| 97 | 25128943 |
US |
82 | 2 |
Wrong technique in product usage process, |
||||
INSULIN GLARGINE, |
||||
| 98 | 25129055 |
US |
53 | |
Wrong technique in product usage process, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 99 | 25129111 |
US |
2 | |
Abdominal pain, Diarrhoea, Drug interaction, Injection site bruising, Wrong technique in product usage process, |
||||
CALCIUM CARBONATE, ERGOCALCIFEROL, ALENDRONATE SODIUM, FOLIC ACID, METHOTREXATE SODIUM, RITUXIMAB, |
||||
| 100 | 25129544 |
IN |
70 | 1 |
Arthritis infective, Neurological symptom, Wrong technique in product usage process, |
||||
LORLATINIB, LORLATINIB, LORLATINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28